chr11-65871247-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_016938.5(EFEMP2):​c.277G>A​(p.Gly93Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00411 in 1,614,018 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. G93G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0033 ( 4 hom., cov: 33)
Exomes 𝑓: 0.0042 ( 16 hom. )

Consequence

EFEMP2
NM_016938.5 missense

Scores

19

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 0.349

Publications

7 publications found
Variant links:
Genes affected
EFEMP2 (HGNC:3219): (EGF containing fibulin extracellular matrix protein 2) A large number of extracellular matrix proteins have been found to contain variations of the epidermal growth factor (EGF) domain and have been implicated in functions as diverse as blood coagulation, activation of complement and determination of cell fate during development. The protein encoded by this gene contains four EGF2 domains and six calcium-binding EGF2 domains. This gene is necessary for elastic fiber formation and connective tissue development. Defects in this gene are cause of an autosomal recessive cutis laxa syndrome. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Jan 2011]
EFEMP2 Gene-Disease associations (from GenCC):
  • cutis laxa, autosomal recessive, type 1B
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P, PanelApp Australia, Ambry Genetics
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen
  • autosomal recessive cutis laxa type 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • lethal arteriopathy syndrome due to fibulin-4 deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • thoracic aortic aneurysm
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0036416352).
BP6
Variant 11-65871247-C-T is Benign according to our data. Variant chr11-65871247-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 424982.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00332 (505/152272) while in subpopulation NFE AF = 0.00515 (350/68008). AF 95% confidence interval is 0.0047. There are 4 homozygotes in GnomAd4. There are 248 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EFEMP2NM_016938.5 linkc.277G>A p.Gly93Ser missense_variant Exon 4 of 11 ENST00000307998.11 NP_058634.4 O95967A0A024R5G1Q9H3D5
EFEMP2NR_037718.2 linkn.402G>A non_coding_transcript_exon_variant Exon 4 of 12

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EFEMP2ENST00000307998.11 linkc.277G>A p.Gly93Ser missense_variant Exon 4 of 11 1 NM_016938.5 ENSP00000309953.6 O95967

Frequencies

GnomAD3 genomes
AF:
0.00331
AC:
504
AN:
152154
Hom.:
4
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000627
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000982
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00962
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00515
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00319
AC:
803
AN:
251426
AF XY:
0.00331
show subpopulations
Gnomad AFR exome
AF:
0.000862
Gnomad AMR exome
AF:
0.000896
Gnomad ASJ exome
AF:
0.000496
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0107
Gnomad NFE exome
AF:
0.00403
Gnomad OTH exome
AF:
0.00440
GnomAD4 exome
AF:
0.00419
AC:
6122
AN:
1461746
Hom.:
16
Cov.:
31
AF XY:
0.00414
AC XY:
3013
AN XY:
727178
show subpopulations
African (AFR)
AF:
0.000807
AC:
27
AN:
33478
American (AMR)
AF:
0.000962
AC:
43
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.000536
AC:
14
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00130
AC:
112
AN:
86248
European-Finnish (FIN)
AF:
0.0101
AC:
541
AN:
53412
Middle Eastern (MID)
AF:
0.00139
AC:
8
AN:
5766
European-Non Finnish (NFE)
AF:
0.00464
AC:
5164
AN:
1111896
Other (OTH)
AF:
0.00353
AC:
213
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
387
773
1160
1546
1933
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
186
372
558
744
930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00332
AC:
505
AN:
152272
Hom.:
4
Cov.:
33
AF XY:
0.00333
AC XY:
248
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.000626
AC:
26
AN:
41560
American (AMR)
AF:
0.000980
AC:
15
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000829
AC:
4
AN:
4826
European-Finnish (FIN)
AF:
0.00962
AC:
102
AN:
10608
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00515
AC:
350
AN:
68008
Other (OTH)
AF:
0.00284
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
30
59
89
118
148
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00357
Hom.:
2
Bravo
AF:
0.00244
TwinsUK
AF:
0.00674
AC:
25
ALSPAC
AF:
0.00363
AC:
14
ESP6500AA
AF:
0.000682
AC:
3
ESP6500EA
AF:
0.00419
AC:
36
ExAC
AF:
0.00287
AC:
349
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Cutis laxa, autosomal recessive, type 1B Benign:5
Feb 04, 2014
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 18, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 31, 2017
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

not provided Benign:3
Nov 30, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 26017485) -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

EFEMP2: BP4, BS2 -

Jul 14, 2017
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: The EFEMP2 c.277G>A (p.Gly93Ser) variant involves the alteration of a non-conserved nucleotide. 2/3 in silico tools predict a benign outcome for this variant (SNPsandGO not captured due to low reliability index). This variant was found in 354/122264 control chromosomes including ExAC, predominantly observed in the European (Finnish) subpopulation at a frequency of 0.009828 (65/6614). This frequency is about 88 times the estimated maximal expected allele frequency of a pathogenic EFEMP2 variant (0.0001118), suggesting this is likely a benign polymorphism found primarily in the populations of European (Finnish) origin. This variant has been found in multiple familial abdominal aortic aneurysm without evidence of segregation (van de Luijtgaarden_2015) and was classified as likely benign by the authors. One diagnostic laboratory has classified uncertain significance without evidence to independently evaluate. Taken together, this variant is classified as benign. -

not specified Benign:2
Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BS1;BP4;BP6 -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Familial thoracic aortic aneurysm and aortic dissection Benign:1
May 16, 2023
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Jan 29, 2019
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
14
DANN
Benign
0.95
DEOGEN2
Benign
0.0043
T;T;.;T
Eigen
Benign
-0.80
Eigen_PC
Benign
-0.70
FATHMM_MKL
Benign
0.092
N
LIST_S2
Benign
0.74
T;T;T;T
M_CAP
Benign
0.031
D
MetaRNN
Benign
0.0036
T;T;T;T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
0.0
.;N;.;.
PhyloP100
0.35
PrimateAI
Benign
0.38
T
PROVEAN
Benign
0.17
N;N;N;N
REVEL
Benign
0.16
Sift
Benign
0.41
T;T;T;T
Sift4G
Benign
0.76
T;T;.;T
Polyphen
0.026
B;B;.;.
Vest4
0.15
MVP
0.56
MPC
0.35
ClinPred
0.0063
T
GERP RS
1.9
Varity_R
0.078
gMVP
0.38
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2234462; hg19: chr11-65638718; COSMIC: COSV57259272; COSMIC: COSV57259272; API